Toho Holdings (8129) Q1 2027 earnings summary

Executive summary

• Net sales increased by 5.84% year-over-year to ¥397,774 million for the three months ended June 30, 2026.

• Operating profit declined by 35.84% year-over-year to ¥2,465 million, and net profit attributable to owners of parent fell by 29.76% to ¥2,355 million.

• Comprehensive income dropped 69.9% year-over-year to ¥853 million.

• The company launched a new Medium-term Management Plan 2026-2028, focusing on innovation and business alliances.

Financial highlights

• Ordinary profit dropped by 14.11% year-over-year to ¥3,810 million.

• Gross profit decreased by 1.93% year-over-year, while SG&A expenses rose by 3.04%.

• Basic earnings per share for Q1 FY2026 was ¥36.24, down from ¥53.61 in Q1 FY2025.

• Total assets as of June 2026 were ¥773,239 million, with net assets at ¥266,193 million and a capital adequacy ratio of 34.4%.

• Pharmaceutical Wholesaling net sales rose 6.23% year-over-year, but operating profit declined by 25.15%.

Outlook and guidance

• The Medium-term Management Plan 2026-2028 aims to drive growth through investments, alliances, and operational reforms.

• FY2027 net sales forecast is ¥1,601,000 million, up 3.1% year-over-year.

• Operating profit forecast is ¥14,800 million, down 10.9% year-over-year.

• Profit attributable to owners of parent is forecast at ¥12,900 million, a 25.6% decrease year-over-year.

• Basic earnings per share forecast for FY2027 is ¥197.67.